GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 12
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Alexis Paschal, Pa, PA | Physician Assistant | Rock Hill, SC | $270.59 | $0 |
| Mr. Stephen Maro, Iii, Np, NP | Family | Winchester, VA | $267.84 | $0 |
| Maria Wilson, Pa, PA | Medical | Glen Burnie, MD | $267.84 | $0 |
| Brad Starkey, M.d, M.D | Anesthesiology | Tulsa, OK | $267.43 | $0 |
| Charlotte Loflin, Aprn-Cnp, APRN-CNP | Gerontology | Round Rock, TX | $267.11 | $0 |
| Luckricia Olivacce, Pa, PA | Medical | Hagerstown, MD | $266.69 | $0 |
| Mark Hall, Pa-C, PA-C | Physician Assistant | Tulsa, OK | $266.52 | $0 |
| Eric Loudermilk, M.d, M.D | Anesthesiology | Anderson, SC | $265.97 | $0 |
| Kelly Wong, Np, NP | Nurse Practitioner | Plantation, FL | $265.03 | $0 |
| Joseph Curletta, Md, MD | Anesthesiology | Gilbert, AZ | $264.17 | $0 |
| Dr. Alicia Lai, Dpm, DPM | Primary Podiatric Medicine | Linwood, NJ | $263.58 | $0 |
| Abe Osbourne, D.p.m, D.P.M | Podiatrist | Cleveland, OH | $262.83 | $0 |
| Dr. Anthony Afong, M.d, M.D | Interventional Pain Medicine | Port St Lucie, FL | $262.70 | $0 |
| Wolf Heberlein, Md, MD | Diagnostic Radiology | Jonesboro, AR | $262.44 | $0 |
| Dr. Rainer Vogel, M.d, M.D | Anesthesiology | Henderson, NV | $262.24 | $0 |
| Melanie New, Apn, APN | Clinical Nurse Specialist | Jonesboro, AR | $261.44 | $0 |
| John Puente, M.d, M.D | Neurology | Fremont, NE | $261.17 | $0 |
| Dr. Charles Murphy, Dpm, DPM | Podiatrist | Linwood, NJ | $261.04 | $0 |
| Sanjay Gupta, Md, MD | Pain Medicine | Bala Cynwyd, PA | $260.44 | $0 |
| Dr. Neil Kirschen, Md, MD | Anesthesiology | Rockville Centre, NY | $258.91 | $0 |
| Dr. Dmitry Arbuck, M.d, M.D | Specialist | Indianapolis, IN | $258.87 | $0 |
| Derek Roper, Pa, PA | Physician Assistant | Easley, SC | $258.58 | $0 |
| Dr. Anthony Mimms, Md, MD | Physical Medicine & Rehabilitation | Indianapolis, IN | $258.53 | $0 |
| Tara Williams-Matney, Arnp, ARNP | Nurse Practitioner | Grundy, VA | $258.51 | $0 |
| Robert Klickovich, M.d, M.D | Pain Medicine | Florence, KY | $257.39 | $0 |
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.